Dr. George Tomlinson, PhD
Claim this profileStudies Post-COVID Syndrome
Studies COVID-19
1 reported clinical trial
4 drugs studied
More about George Tomlinson, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments George Tomlinson, PhD has experience with
- Ibudilast
- Pentoxifylline
- Placebo
- Whey Protein Isolate
Breakdown of trials George Tomlinson, PhD has run
Post-COVID Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does George Tomlinson, PhD specialize in?
George Tomlinson, PhD focuses on Post-COVID Syndrome and COVID-19. In particular, much of their work with Post-COVID Syndrome has involved treating patients, or patients who are undergoing treatment.
Is George Tomlinson, PhD currently recruiting for clinical trials?
No, George Tomlinson, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that George Tomlinson, PhD has studied deeply?
Yes, George Tomlinson, PhD has studied treatments such as Ibudilast, Pentoxifylline, Placebo.
What is the best way to schedule an appointment with George Tomlinson, PhD?
Apply for one of the trials that George Tomlinson, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.